2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Urinary Bladder Neoplasms
2
Hyperthermia
2
Breast Neoplasms
2
Uveal Melanoma
1
Ureteral Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Retinoblastoma
1
Prostatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
Cisplatin
57
Radiotherapy
35
Radiotherapy, Intensity-Modulated
30
Magnetic Resonance Spectroscopy
24
Radiation
21
Carboplatin
19
pembrolizumab
18
Specimen Handling
16
Platinum
14
Cetuximab
14
1,2-diaminocyclohexaneplatinum II citrate
14
Surveys and Questionnaires
13
Paclitaxel
13
Biopsy
11
Surgical Procedures, Operative
10
Fluorouracil
10
Docetaxel
9
Taxes
8
Nivolumab
8
Drug Therapy
8
Chemoradiotherapy
8
durvalumab
7
Fluorodeoxyglucose F18
7
Observation
6
Blood Specimen Collection
6
fludarabine
5
X-Rays
5
Immunohistochemistry
5
Cyclophosphamide
5
aldesleukin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
Hyperthermia, Induced
×
Clear all
NCT06761937
2025-07-25
TANCA-I
Erasmus Medical Center
Phase 1
Recruiting
30 enrolled